- Expands facilities in Los Angeles, Frankfurt, Edinburgh and Beijing
RESEARCH TRIANGLE PARK, North Carolina, Aug. 23, 2012 /PRNewswire/ -- Marken announced today the opening of four expanded branch facilities to meet the continued growth of their business.
(Logo: http://photos.prnewswire.com/prnh/20110930/NY78064LOGO )
In Los Angeles, Marken significantly expanded its office and warehouse space adjacent to its existing LAX facility in order to reflect the growing demand for complex clinical drug distribution and biological sample shipments from their US west coast clients. In Beijing, Marken will move into a new facility which will allow the planned build out of their new pharmaceutical services depot while allowing sufficient space for branch logistics operations. In Edinburgh, Scotland, Marken has moved into expanded office and warehouse space adjacent to the airport and close to its previous office. In Germany, Marken has relocated its branch operations into a new facility near the Frankfurt airport which will also become the home of Marken's European central depot.
"Due to the growing demand for complex IMP and biomarker shipments, we have decided to enhance our facilities and expand our operations in these strategic locations. We have taken this unique opportunity to combine our planned depot strategy with our need for expanded logistics operations and will combine them wherever possible. It makes sense to leverage our proven logistics expertise with our depots and thus offer our clients a complete service in the clinical logistics market," said Wes Wheeler, Chief Executive Officer for Marken. "We will be announcing further details about our depot expansion in the near future, and will remain flexible as we continue to meet the needs of our clients."
About Marken
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment in naive geographies.
Share this article